Policies and Guidelines

IRB Office Contact

The 330 Building, Suite 205, University Park, PA 16802
Phone: 814-865-1775 • Fax: 814-863-8699
Email: IRB-ORP@psu.edu

The IRB committees and staff are responsible for reviewing and approving, requiring modifications, or withholding approval of research involving human subjects.

Office Directory

For all updates on mitigating the impacts of COVID-19 on research programs at Penn State, Click Here >>

Effective March 15, 2020: Revised standards for Human Subjects-Related Research Visits during COVID-19

In the context of rapidly evolving circumstances regarding COVID-19, and the University’s focus on social distancing and the health and well-being of the community, the Office of the Senior Vice President for Research, in consultation with Vice Dean for Research and Graduate Studies in the College of Medicine, has issued these revised standards related to human subjects-related research visits. In summary, research visits should be performed remotely (e.g., by phone, Zoom, or other means) whenever possible. Studies involving face-to-face interaction with participants with no direct drug or device therapeutic benefit are to be postponed until further notice, effective March 15, 2020. Please review the standards carefully: https://psu.box.com/v/COVIDResearchVisits.

FAQs can be found here: https://www.research.psu.edu/covid_irb.

The following policies and guidelines give context to various regulations that impact IRB approval.

IRB Guidelines

Penn State Policies

FERPA and HIPAA

Federal Policies

Codes of Federal Regulations

Office for Human Research Protections

National Institute of Health

Other Guidelines